Similarly, Wang et al. [42] found that berberine promoted SIRT1-mediated deacetylation of CPT1A at the Lys675 site, reducing ubiquitin-dependent degradation of CPT1A and ameliorating NASH. This evidence concerns the gene CPT1A and metabolic dysfunction-associated steatohepatitis.